LivaNova (LIVN) Return on Invested Capital Growth (3y) (2019 - 2026)
LivaNova (LIVN) Return on Invested Capital Growth (3y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROIC Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.74 Bn | 194.14 Bn | 7.27 Bn | 0.00 |
| 2 | Stryker | 129.74 Bn | 126.26 Bn | 4.50 Bn | 0.00 |
| 3 | Medtronic | 119.78 Bn | 110.56 Bn | 6.41 Bn | 1.00 |
| 4 | Boston Scientific | 73.98 Bn | 73.44 Bn | 3.85 Bn | 0.00 |
| 5 | Edwards Lifesciences | 52.45 Bn | 48.19 Bn | 1.35 Bn | - |
| 6 | Dexcom | 34.74 Bn | 32.79 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 34.12 Bn | 32.01 Bn | 2.18 Bn | -85.00 |
| 8 | Koninklijke Philips | 26.41 Bn | 23.09 Bn | 4.55 Bn | 0.00 |
| 9 | Steris | 23.26 Bn | 22.77 Bn | 684.20 Mn | 2.00 |
| 10 | LivaNova | 4.32 Bn | 3.80 Bn | 273.67 Mn | 3.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 3.00 |
| Mar 31, 2026 | 2.00 |
| Dec 31, 2025 | 1.00 |
| Sep 30, 2025 | 1.00 |
| Jun 30, 2025 | 1.00 |
| Mar 31, 2025 | 1.00 |
| Dec 31, 2024 | 1.00 |
| Sep 30, 2024 | 1.00 |
| Jun 30, 2024 | 2.00 |
| Mar 31, 2024 | 2.00 |
| Dec 31, 2023 | 1.00 |
| Sep 30, 2023 | 0.00 |
| Jun 30, 2023 | -1.00 |
| Mar 31, 2023 | -1.00 |
| Dec 31, 2022 | 0.00 |
| Sep 30, 2022 | 1.00 |
| Jun 30, 2022 | 2.00 |
| Mar 31, 2022 | 1.00 |
| Dec 31, 2021 | 1.00 |
| Sep 30, 2021 | -1.00 |